Origin House (CSE:OH) announced a binding term sheet with Alternative Medical Enterprises (AltMed) to alter its agreement in order to raise its equity position in AltMed.

As quoted in the press release:


Origin House a leading North American cannabis products and brands company, today announced that it has signed a binding term sheet (the “Agreement”) with Alternative Medical Enterprises, LLC (“AltMed”) to convert the Company’s 3.5 [percent] royalty interest on the sale of AltMed’s MÜV branded products (“MÜV”) into a combination of cash and 125 units of AltMed’s equity raising Origin House’s aggregate equity position in AltMed to 5.1 [percent].

Marc Lustig, Chairman and CEO of Origin House said, “AltMed has established itself as a successful cannabis business in the key markets of Florida and Arizona. Based on our discussions with AltMed, we believe eliminating the royalty will facilitate the multi-jurisdictional expansion of MÜV products and also furthers our strategic aim of converting non-core assets like the MÜV royalty.”

Transaction Details:

Origin House currently owns a 4.8 [percent] equity interest in AltMed and a 3.5 [percent] gross product royalty on the sale of certain MÜV products. Pursuant to the Agreement, AltMed will issue 125 units to Origin House in addition to cash, as consideration for the Company’s royalty interest. Upon conversion of the royalty interest, Origin House will own an aggregate of 5.1 [percent] of AltMed. Based on the valuation ascribed to AltMed for the conversion of the royalty, this 5.1 [percent] equity position has an equity value of US$10.3 million. The anticipated closing date is on or before February 15, 2019.

Click here to read the full press release.

Ayurcann Holdings Corp. (CSE: AYUR) (the “Company” or “Ayurcann”) an integrated Canadian extraction company specializing in the processing of cannabis and hemp for the production of oils and various derivative products, announces the granting of stock options and restricted share units.

The Company has announced that it has granted incentive stock options to directors, officers, employees and consultants of the Company to purchase an aggregate of 1,000,100 common shares under the Company’s Stock Option Plan. Each option is exercisable at a price of $0.16 per common share, expires three years from the date of grant and vest six months from the date of the grant.

Keep reading... Show less

A planned business merger between two leading cannabis producers hit a small delay this week as a critical vote got moved.

Meanwhile, a cannabis retail operator elected to celebrate 420 by auctioning a cannabis-themed digital art piece using blockchain technology.

Keep reading... Show less

Partnerships with Minardi Law , Minorities for Medical Marijuana, CultivatED, and the Georgia Justice Project will include clinics and virtual events across Florida , Georgia , and Massachusetts

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today a series of expungment clinics located throughout south and central Florida as well as virtual events in Georgia and Massachusetts . The clinics are part of the Company’s celebration of the 50 th anniversary of 420.

Keep reading... Show less

Seth Rogen’s New Cannabis Brand are Now Available at Apothecarium Dispensaries in San Francisco , Berkeley and Capitola

The Apothecarium is offering cannabis from Houseplant, the cannabis lifestyle brand founded by Seth Rogen and Evan Goldberg at its five California dispensaries. The Apothecarium has three San Francisco locations (Castro, SOMA and Marina ) and one each in Berkeley and Capitola (outside of Santa Cruz ).

Keep reading... Show less